RankAlpha logo
Back to Rankings

FULC

Fulcrum TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
FULC vs peer average
15/100
FULC vs. peer average (F vs. B)
Grade spread
A 3 · B 2 · C 2 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

EPRX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $429.26M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerEPRXEupraxia
FULC
Fulcrum Therapeutics
EPRX
Eupraxia
Grade
F
B
Momentum
5
34
Value
41
41
Sentiment
-
100
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs EPRX

FULC / EPRX
Grade Position
Below peers
FULC vs. peer average (F vs. B)
15/100
Momentum
5
EPRX
Value
41
FULC
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs FULC
1
EPRX
Eupraxia Pharmaceuticals Inc Common
B
80/100
-3
2
EOLS
Evolus Inc Common
A
100/100
-4
3
IPSC
Century Therapeutics Inc Common
F
20/100
Even
4
MNPR
Monopar Therapeutics Inc Common
A
100/100
-4
5
ADCT
ADC Therapeutics Ltd Common
C
60/100
-2
EPRX is the first peer returned for this comparison set.